Resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queens.

Deslorelin implants are widely used in felines. Due to their prolonged duration cat breeders frequently request early implant removal. The interval between deslorelin implant removal and resumption of ovarian function in queens is unknown. The aim of this study was to evaluate the interval between the removal of a deslorelin implant and the resumption of ovarian activity in adult queens. Twenty-three queens were treated with a 4.7 mg deslorelin implant placed in the periumbilical area. In the 16 queens completing the study implants were surgically removed at 3, 6 or 9 months (n= 6, 4 and 6 queens, respectively). Queens received a GnRH stimulation test as part of their pre-treatment general and reproductive health check. Starting 7-14 days following implant removal queens were checked every 1-2 weeks with reproductive ultrasonography, a vaginal smear and blood collection. Following implantation treatment, all queens in interestrus-anestrus at the time of treatment came in estrus within 2-5 days. The interval to resumption of ovarian function ranged from 3 to 7 weeks irrespective of treatment length and age of the queen but was longer when the implant was removed at decreasing photoperiod (p < .05). In conclusion, at least 3 weeks post-removal are needed during increasing photoperiod to achieve follicular development and estrogen production sufficient to support estrous behavior in queens following removal of a 4.7 mg deslorelin implant, while this time may increase up to 7 weeks during decreasing photoperiod. Further studies are needed in order to assess the interval between removal of a deslorelin implant and occurrence of ovulation as well as fertility at the first estrous after a deslorelin treatment.

[1]  S. Romagnoli,et al.  Interval between Removal of a 4.7 mg Deslorelin Implant after a 3-, 6-, and 9-Month Treatment and Restoration of Testicular Function in Tomcats , 2020, Animals : an open access journal from MDPI.

[2]  S. Romagnoli,et al.  Disappearance of signs of heat and induction of ovulation in oestrous queens with gonadorelin: a clinical study , 2020, Journal of feline medicine and surgery.

[3]  S. Romagnoli,et al.  Length of efficacy and effect of implant location in adult tom cats treated with a 9.4 mg deslorelin subcutaneous implant , 2018, Journal of feline medicine and surgery.

[4]  M. Yeste,et al.  Placental and uterine expression of GLUT3, but not GLUT1, is related with serum progesterone levels during the first stages of pregnancy in queens. , 2018, Theriogenology.

[5]  S. Romagnoli,et al.  Postponement of puberty in queens treated with deslorelin , 2017, Journal of feline medicine and surgery.

[6]  S. Romagnoli,et al.  Semen quality and interval to sterility in tom cats treated with a 9.4 mg deslorelin implant , 2017, Journal of feline medicine and surgery.

[7]  R. Payan-Carreira,et al.  Fertility in Adult Bitches Previously Treated with a 4.7 mg Subcutaneous Deslorelin Implant. , 2015, Reproduction in domestic animals = Zuchthygiene.

[8]  D. Zambelli,et al.  First deliveries after estrus induction using deslorelin and endoscopic transcervical insemination in the queen. , 2015, Theriogenology.

[9]  C. Fontaine Long-term contraception in a small implant , 2015, Journal of feline medicine and surgery.

[10]  C. Phillips,et al.  A Reproductive Management Program for an Urban Population of Eastern Grey Kangaroos (Macropus giganteus) , 2014, Animals.

[11]  S. Johnston,et al.  Inhibition of the Reproductive System by Deslorelin in Male and Female Pigeons (Columba livia) , 2014, Journal of avian medicine and surgery.

[12]  M. Veronesi,et al.  Effectiveness of deslorelin acetate subcutaneous implantation in a domestic queen with after-spaying urinary incontinence , 2014, Journal of feline medicine and surgery.

[13]  A. Wehrend,et al.  Treatment with Suprelorin in a pregnant cat , 2013, Journal of feline medicine and surgery.

[14]  A. Wehrend,et al.  Treatment of queens in estrus and after estrus with a GnRH-agonist implant containing 4.7 mg deslorelin; hormonal response, duration of efficacy, and reversibility. , 2013, Theriogenology.

[15]  M. Beccaglia,et al.  Prediction of parturition in dogs and cats: accuracy at different gestational ages. , 2012, Reproduction in domestic animals = Zuchthygiene.

[16]  C. Barbeito,et al.  Long-term-release GnRH agonists postpone puberty in domestic cats. , 2012, Reproduction in domestic animals = Zuchthygiene.

[17]  S. Romagnoli,et al.  Semen quality and onset of sterility following administration of a 4.7-mg deslorelin implant in adult male dogs. , 2012, Reproduction in domestic animals = Zuchthygiene.

[18]  E. Trevisol,et al.  Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens. , 2012, Theriogenology.

[19]  V. Olgac,et al.  Effects of the GnRH analogue deslorelin implants on reproduction in female domestic cats. , 2012, Theriogenology.

[20]  A. Wehrend,et al.  Clinical efficacy of a GnRH-agonist implant containing 4.7 mg deslorelin, Suprelorin, regarding suppression of reproductive function in tomcats. Sandra.Pesch@vetmed.uni-giessen.de. , 2011, Theriogenology.

[21]  W. Heuwieser,et al.  Follicular cysts and prolonged oestrus in a female dog after administration of a deslorelin implant , 2011, New Zealand veterinary journal.

[22]  S. Romagnoli,et al.  Clinical use of deslorelin for the control of reproduction in the bitch. , 2009, Reproduction in domestic animals = Zuchthygiene.

[23]  F. de Jong,et al.  Use of a gonadotropin releasing hormone agonist implant as an alternative for surgical castration in male ferrets (Mustela putorius furo). , 2008, Theriogenology.

[24]  M. Driancourt,et al.  Treatment with a subcutaneous GnRH agonist containing controlled release device reversibly prevents puberty in bitches. , 2006, Theriogenology.

[25]  T. Trigg,et al.  Applications of GnRH in the control and management of fertility in female animals. , 2005, Animal reproduction science.

[26]  A. Padula GnRH analogues--agonists and antagonists. , 2005, Animal reproduction science.

[27]  G. Martin,et al.  Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs. , 2003, Reproduction, fertility, and development.

[28]  G. Martin,et al.  Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. , 2001, Journal of reproduction and fertility. Supplement.

[29]  C. Asa,et al.  Efficacy of the GnRH analogue deslorelin for suppression of oestrous cycles in cats. , 2001, Journal of reproduction and fertility. Supplement.

[30]  T. Tsutsui,et al.  Biology of ovarian cycles, pregnancy and pseudopregnancy in the domestic cat. , 1993, Journal of reproduction and fertility. Supplement.